{'fraction_non_alphanumeric': 0.025186567164179104, 'fraction_numerical': 0.008395522388059701, 'mean_word_length': 5.349112426035503, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Access to Second-Line Antiretroviral Therapeutic Regimens in Low-Resource Settings: Experiences From Cameroon

Cameroon is one of the few sub-Saharan countries engaged in the implementation of a universal public health policy on HIV/AIDS. In May 2007, second-line antiretroviral regimens were made available in the country; thanks to the joint participation of the Cameroonian government and the UNITAID/Clinton Foundation HIV/AIDS Initiative. This cooperation was achieved by means of a Memorandum of Understanding. The agreement aimed at providing free-of-charge access of 8 antiretroviral formulations. Nevertheless, only 1.9% of the estimated 16% patients that are presently in need of second-line regimens has access to these medicines. The main hindrances to achieving scaled-up access refer to the new institutional arrangements that are necessary for the demand and distribution of these medicines, the limiting conditions for the therapeutic monitoring of second-line treatments, at the national level and the governance of the Memorandum of Understanding itself.